Advanced Clinical Announces Eman Albazzaz as new Executive Director of Regulatory Affairs

Ms. Albazzaz is an accomplished regulatory affairs and pharmacovigilance executive with a history of successfully leading global regulatory strategy, risk-management strategy, and pharmacovigilance. An expert in systems thinking and execution of high-quality management processes, Ms. Albazzaz formulates vision, builds organizations, and provides guidance in the establishment of effective policies, procedures, and global training programs.

Ms. Albazzaz is known for her global pharmaceutical industry expertise. She was most recently Vice President of Risk Management for Lundbeck, Inc. (formerly Ovation Pharmaceuticals). Prior to that, she was Vice President for International Regulatory Affairs at Ovation, where she was responsible for global pharmacovigilance.

“We are very excited to welcome Eman's leadership to the Advanced Clinical team,” said Dr. Christina Fleming, Executive Vice President, Scientific and Medical Affairs. “Her high-level expertise and regulatory knowledge as well as her passion for business development and growth are a perfect fit for Advanced Clinical's goals and strategy.”
Leo Sheridan, CEO of Advanced Clinical, echoes Dr. Fleming's sentiment. “We are honored to bring Eman's caliber and experience to our team. Her commitment to life sciences innovation is unparalleled, and her insight is a critical asset to the industry and our company.”
Ms. Albazzaz earned her Bachelor of Science degree (with honors) in Pharmacy from Baghdad University College of Pharmacy, Baghdad, Iraq, where she also held multiple positions in teaching Pharmacology and Toxicology. She is an active member of the Drug Information Association, the Parenteral Drug Association, and the American Society of Health System Pharmacists. Ms. Albazzaz resides in the Chicagoland area and will be based out of Advanced Clinical's headquarters in Deerfield, IL.